Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

Published:2003-08 Issue:8 Volume:9 Page:505-511
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ratanatharathorn Voravit,Ayash Lois,Reynolds Christopher,Silver Samuel,Reddy Pavan,Becker Michael,Ferrara James L.M,Uberti Joseph P

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference33 articles.

1. Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease;Arora;Biol Blood Marrow Transplant,2001

2. Therapy for chronic graft-versus-host disease;Koc;Blood,2002

3. Chronic graft-versus-host disease;Ratanatharathorn;Bone Marrow Transplant,2001

4. Advances in transplantation tolerance;Yu;Lancet,2001

5. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease;Ratanatharathorn;Ann Intern Med,2000

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the ocular complications after hematopoietic stem cell transplantation;Annals of Hematology;2024-02-26

2. The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation;Expert Review of Hematology;2023-11-06

3. Insights and strategies to promote immune tolerance in allogeneic hematopoietic stem cell transplantation recipients;Translational Autoimmunity;2023

4. Chronic GvHD NIH Consensus Project Biology Task Force: Evolving path to personalized treatment of chronic GvHD;Blood Advances;2022-11-02

5. Mature Naive B Cells Regulate the Outcome of Murine Acute Graft-versus-Host Disease in an IL-10-Independent Manner;Transplantation and Cellular Therapy;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3